BHSRX: BlackRock Health Sciences Opportunities Portfolio - MutualFunds.com
Continue to site >
Trending ETFs

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

BlackRock Health Sciences Opps R

BHSRX - Snapshot

Vitals

  • YTD Return 6.3%
  • 3 Yr Annualized Return 17.1%
  • 5 Yr Annualized Return 15.1%
  • Net Assets $11 B
  • Holdings in Top 10 36.6%

52 WEEK LOW AND HIGH

$76.04
$64.10
$76.72

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.45%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 28.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $100
  • IRA N/A

Fund Classification


Compare BHSRX to Popular Health Care Sector Equity Funds and ETFs

Overview

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

$233.38

-0.48%

$49.75 B

0.92%

$2.16

8.19%

0.32%

$125.17

+0.77%

$27.65 B

1.37%

$1.70

10.34%

0.13%

$106.04

+1.00%

$18.04 B

-

$0.00

7.27%

0.76%

$121.36

-0.36%

$17.26 B

1.19%

$1.45

8.44%

0.10%

$244.77

+0.85%

$17.26 B

1.20%

$2.90

9.40%

0.10%

BHSRX - Profile

Distributions

  • YTD Total Return 6.3%
  • 3 Yr Annualized Total Return 17.1%
  • 5 Yr Annualized Total Return 15.1%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.32%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    BlackRock Health Sciences Opportunities Portfolio
  • Fund Family Name
    BlackRock
  • Inception Date
    Sep 12, 2011
  • Shares Outstanding
    N/A
  • Share Class
    Retirement
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Erin Xie

Fund Description

The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.


BHSRX - Performance

Return Ranking - Trailing

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
YTD 6.3% -12.5% 23.0% 51.16%
1 Yr 18.5% -1.4% 110.6% 61.90%
3 Yr 17.1%* 3.2% 43.8% 14.86%
5 Yr 15.1%* 3.7% 37.4% 26.24%
10 Yr 15.9%* 8.4% 18.8% 34.15%

* Annualized

Return Ranking - Calendar

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
2020 14.2% -13.6% 178.2% 50.31%
2019 20.2% 3.8% 63.8% 55.17%
2018 -0.2% -49.7% 21.5% 21.90%
2017 20.0% -59.8% 54.4% 46.67%
2016 -8.6% -36.6% 11.6% 23.44%

Total Return Ranking - Trailing

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
YTD 6.3% -12.5% 23.0% 50.58%
1 Yr 18.5% -1.4% 110.6% 55.36%
3 Yr 17.1%* 3.2% 43.8% 14.19%
5 Yr 15.1%* 3.7% 37.4% 23.40%
10 Yr 15.9%* 8.4% 18.8% 33.33%

* Annualized

Total Return Ranking - Calendar

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
2020 14.2% -13.6% 178.2% 50.31%
2019 20.2% 3.8% 63.8% 55.17%
2018 -0.2% -25.3% 22.2% 29.20%
2017 24.3% -10.8% 54.4% 28.15%
2016 -6.4% -36.6% 11.6% 19.53%

NAV & Total Return History


BHSRX - Holdings

Concentration Analysis

BHSRX Category Low Category High BHSRX % Rank
Net Assets 11 B 6.68 M 49.7 B 7.51%
Number of Holdings 170 25 506 13.29%
Net Assets in Top 10 4.04 B 1.53 M 19.3 B 9.83%
Weighting of Top 10 36.55% 8.9% 78.2% 55.49%

Top 10 Holdings

  1. UnitedHealth Group Inc 6.47%
  2. Abbott Laboratories 5.08%
  3. Johnson & Johnson 4.31%
  4. Medtronic PLC 4.05%
  5. Thermo Fisher Scientific Inc 2.92%
  6. Eli Lilly and Co 2.90%
  7. Boston Scientific Corp 2.84%
  8. Humana Inc 2.81%
  9. Cigna Corp 2.77%
  10. Amgen Inc 2.63%

Asset Allocation

Weighting Return Low Return High BHSRX % Rank
Stocks
98.84% 82.66% 105.23% 48.55%
Other
1.12% -26.63% 8.98% 15.61%
Cash
0.04% -0.13% 17.34% 79.77%
Preferred Stocks
0.00% 0.00% 5.58% 100.00%
Convertible Bonds
0.00% 0.00% 0.02% 100.00%
Bonds
0.00% 0.00% 18.37% 100.00%

Stock Sector Breakdown

Weighting Return Low Return High BHSRX % Rank
Healthcare
98.82% 63.71% 100.00% 65.90%
Basic Materials
0.66% 0.00% 3.68% 24.28%
Financial Services
0.52% 0.00% 3.21% 13.87%
Utilities
0.00% 0.00% 0.00% 100.00%
Technology
0.00% 0.00% 19.82% 100.00%
Real Estate
0.00% 0.00% 6.18% 100.00%
Industrials
0.00% 0.00% 6.41% 100.00%
Energy
0.00% 0.00% 0.00% 100.00%
Communication Services
0.00% 0.00% 8.10% 100.00%
Consumer Defense
0.00% 0.00% 29.47% 100.00%
Consumer Cyclical
0.00% 0.00% 14.16% 100.00%

Stock Geographic Breakdown

Weighting Return Low Return High BHSRX % Rank
US
89.88% 58.55% 101.51% 33.53%
Non US
8.96% 0.00% 40.32% 66.47%

BHSRX - Expenses

Operational Fees

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.45% 0.08% 7.05% 33.73%
Management Fee 0.67% 0.00% 1.25% 57.71%
12b-1 Fee 0.50% 0.00% 1.00% 69.74%
Administrative Fee N/A 0.03% 0.25% 25.00%

Sales Fees

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 28.00% 3.00% 256.00% 26.54%

BHSRX - Distributions

Dividend Yield Analysis

BHSRX Category Low Category High BHSRX % Rank
Dividend Yield 0.00% 0.00% 0.95% 100.00%

Dividend Distribution Analysis

BHSRX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Annually Annually

Net Income Ratio Analysis

BHSRX Category Low Category High BHSRX % Rank
Net Income Ratio -0.32% -2.54% 1.74% 69.41%

Capital Gain Distribution Analysis

BHSRX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

BHSRX - Fund Manager Analysis

Managers

Erin Xie


Start Date

Tenure

Tenure Rank

Jul 31, 2003

17.85

17.9%

Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.

Xiang Liu


Start Date

Tenure

Tenure Rank

Jun 01, 2020

1.0

1.0%

Jeff Lee


Start Date

Tenure

Tenure Rank

Jun 01, 2020

1.0

1.0%

Tenure Analysis

Category Low Category High Category Average Category Mode
0.04 23.72 7.22 21.1